Some types of breast cancer have a high incidence of contra-lateral occurrence. To provide the best service to the patient every breast evaluation for cancer should include not only the affected but also the contra-lateral breast. Since contrast agents Gd can only be administered once for the dynamic evaluation of...
Dense breasts contain more glandular tissue, and breast cancer is also made up of dense tissue. Oftentimes both cancer and normal breast glandular tissue appear dense on a mammogram, making it difficult to find a cancer in the midst of normal glandular tissue. Researchers are studying other screening methods, such...
After the exposure, the image is transferred to the Acquisition Workstation AWS. OpView, Siemens' new advanced image processing software, provides excellent visibility of the breast border and structures in dense breasts. In addition, OpView has an extended application range and allows for more individual configurations. The image is displayed at...
This paper describes about the development in the technology for and evaluates the utility of a 0.5-T vertical open-configuration magnetic resonance MR imaging system for imaging-guided breast lumpectomy of malignant tumors. All breast lesions were identified despite limited spatial resolution and fat-suppression techniques. The evolved techniques facilitated intraoperative margin evaluation...
New Indication for Known CNS Drug Initially Predicted by Discovery Platform TEL AVIV, Israel -- Compugen Ltd. (NASDAQ:CGEN) announced today that it has begun the planning for a proof of concept human trial for breast cancer therapy in 2009 for CGEN-50001, a known central nervous system ("CNS") drug....
MONROVIA, Calif. -- Prolacta Bioscience has announced that the American Academy of Pediatrics 2008 National Conference and Exhibition has accepted their abstract demonstrating the effects of human milk-based human milk fortifier on pre-term infants. The American Academy of Pediatrics 2008 National Conference and Exhibition NCE will take place October 11-14,...
Updated findings from an analysis of existing research continue to suggest that the oft-touted monthly breast self-exam may actually do more harm than good. There is no evidence that the practice actually decreases deaths from breast cancer while it may actually double the number of unnecessary biopsies in women who...
"So, you've had a mastectomy," said the plastic surgeon. I glanced down at my breasts, which were still there. No, I hadn't, unless I'd been even more forgetful than usual, had a mastectomy. But I'd been told that I'd need one. The lumpectomy on my left breast hadn't quite cut...
New Hires Add to Company's Growth; Rapidly Advancing Proprietary Non-Invasive Cancer Diagnostic Technology SAN DIEGO & LEXINGTON, Mass. -- Predictive Biosciences, an emerging molecular diagnostics company developing non-invasive diagnostic products for informed cancer management[TM], today announced the appointment of two senior executives: Ellen Sheets, M.D., to the newly...
Growing Awareness of Vitamin D Deficiencies Sparks Sharp Rise in Vitamin D Testing SCOTTSDALE, Ariz. -- Baywood International, Inc. (OTCBB:BAYW) ("Company") announced that three of the largest testing labs in the United States, Quest Diagnostics, Lab Corp. of America and the Mayo Clinic, have all reported a sharp...
Provista Life Sciences LLC PLS, a diagnosticdevelopment and commercialization company, today announced that ChristaCorn, M.D. has signed on to serve as its resident physician for the BT Test , a bloodtest for the early detection ofbreast cancer . With Dr. Corn in this role, women will now be...
Oklahoma Cares, a breast and cervical cancer treatment program, received high marks on a recent survey measuring member satisfaction. The program provides health care benefits to low-income women between the ages of 19 and 65 who have no creditable health insurance coverage for breast or cervical cancer....
CHICAGO -- Zacks Equity Research highlights Genentech (NYSE: DNA) as the Bull of the Day and Primus Guaranty (NYSE: PRS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Power Integrations, Inc. (Nasdaq: POWI), Unibanco S.A. (NYSE: UBB) and Amdocs, Ltd. (NYSE: DOX). ...
World's Largest Breast Cancer Organization Standardizes on Convio's Online Communication, Fundraising, Advocacy Suite, Content Management System and New Constituent Relationship Management Offering to Improve Efficiency and Effectiveness AUSTIN, Texas -- Susan G. Komen for the Cure[R], the global leader in the breast cancer movement, and Convio, a leading...
Introduction of Oxygen-based Product (EZ-646) to the Company's Galactomannan-C (DAVANAT([c])) with 5-FU to Treat All Solid Tumors, especially Head & Neck, Breast & Colorectal This Study is in Addition to the Company's Ongoing Phase II Clinical Trials of DAVANAT([c] )with 5-FU to Treat Colorectal & Biliary Cancer ...
CHATSWORTH, Calif. -- North American Scientific (NASDAQ:NASM) announced today that it has appointed Robin Gibbs to the position of Vice President of Marketing. Ms. Gibbs, formerly a Vice President of Global Franchise Management for Edwards Lifesciences, will lead the marketing team for the company's growing Radiation Sources division, including the...
How soon should I breastfeed my baby? Unless your baby needs immediate medical attention, you should have skin-to-skin contact with your baby right away. You should breastfeed your baby within the first hour after giving birth, even if this means you have to wait to weigh or bathe...
Medicare patients receive varying quality of care depending on their geographic location and race, according to a study of Medicare enrollment and claims data for patients 65 years and older. "Disparities in Health and Health Care Among Medicare Beneficiaries" found health care disparities in diabetes testing, breast cancer screening, and...
AMSTERDAM, The Netherlands and BARCELONA, Spain, July 15 /PRNewswire-FirstCall/ -- Agendia BV and Ferrer inCode today announced an agreement that will give Ferrer exclusive rights to sell two of Agendia's signature cancer diagnostic services -- MammaPrintR, a prognostic test that uses a 70-gene signature to indicate risk of breast...
HOUSTON -- Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for breast cancer and neurodegenerative diseases, today announced a new major international collaboration. Power3, in partnership with the Princess Haya Biotechnology Center and the Jordan University of Science...
Articles 2008-07-15
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
